{
    "2018-12-06": [
        [
            {
                "time": "2018-03-15",
                "original_text": "AbbVie Stock Has a $10 Upside Opportunity â€” Buy It Now",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock",
                        "Upside",
                        "Opportunity",
                        "Buy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "AbbVie Falls 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Falls",
                        "3%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-17",
                "original_text": "AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Halts",
                        "Rova-T",
                        "Phase",
                        "III",
                        "Lung",
                        "Cancer",
                        "Study"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-18",
                "original_text": "The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",
                "features": {
                    "keywords": [
                        "Daily",
                        "Biotech",
                        "Pulse",
                        "AbbVie",
                        "Halts",
                        "Lung",
                        "Cancer",
                        "Trial",
                        "Oncomed",
                        "Merges",
                        "Mereo",
                        "Momenta",
                        "Offering"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}